regulatory
confidence high
sentiment negative
materiality 0.70
RenovoRx, Inc. (RNXT): Nasdaq/NYSE listing notice — RenovoRx receives Nasdaq deficiency notice for minimum bid price non-compliance
RenovoRx, Inc.
- Received Nasdaq notice Dec 31, 2025; closing bid price below $1.00 for 32 consecutive business days.
- Has 180 calendar days, until June 30, 2026, to regain compliance by closing at $1.00 for 10 consecutive days.
- If non-compliant by June 30, 2026, may qualify for an additional 180-day period with reverse stock split option.
- Failure to cure could lead to delisting from Nasdaq Capital Market.